Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-03-2016 | Review Article

Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma

Authors: Aroonima Misra, Jyoti Mishra, Jagan Chandramohan, Atul Sharma, Vinod Raina, Rajive Kumar, Sushant Soni, Anita Chopra

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2016

Login to get access

Abstract

Introduction: High resolution electrophoresis (HRE) and immunofixation (IFX) of serum and urine are integral to the diagnostic work-up of multiple myeloma. Unusual electrophoresis patterns are common and may be misinterpreted. Though primarily the responsibility of the hematopathologist, clinicians who are responsible for managing myelomas may benefit from knowledge of these. In this review article we intend to discuss the patterns and importance of electrophoresis in present day scenario. Methods: Patterns of HRE and IFX seen in our laboratory over the past 15 years were studied. Results: Monoclonal proteins are seen on HRE as sharply defined bands, sometimes two, lying from γ- to α-globulin regions on a background of normal, increased or decreased polyclonal γ-globulins, showing HRE to be a rapid and dependable method of detecting M-protein in serum or urine. Immunofixation complements HRE and due to its greater sensitivity, is able to pick up small or light chain bands, not apparent on electrophoresis, including biclonal disease even when electrophoresis shows only one M-band. Special features liable to misinterpretation are discussed. Familiarity with the interpretation of the varied patterns seen in health and disease is essential for providing dependable laboratory support in the management of multiple myeloma.
Literature
1.
go back to reference Harding SJ, Mead GP, Bradwell AR, Berard AM (2009) Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies. Clin Chem Lab Med 47:302–304CrossRefPubMed Harding SJ, Mead GP, Bradwell AR, Berard AM (2009) Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies. Clin Chem Lab Med 47:302–304CrossRefPubMed
2.
go back to reference Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R et al (2009) International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 23:215–224CrossRefPubMed Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R et al (2009) International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 23:215–224CrossRefPubMed
3.
go back to reference Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467–1473CrossRefPubMed Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467–1473CrossRefPubMed
4.
go back to reference Anand M, Kumar R, Sharma OD (2004) Economical choices in setting up a diagnostic myeloma laboratory. Indian J Pathol Microbiol 47:506–508PubMed Anand M, Kumar R, Sharma OD (2004) Economical choices in setting up a diagnostic myeloma laboratory. Indian J Pathol Microbiol 47:506–508PubMed
5.
go back to reference Keren DF, Warren JS (1992) Diagnostic immunology. Lippincott Williams and Wilkins, Maryland Keren DF, Warren JS (1992) Diagnostic immunology. Lippincott Williams and Wilkins, Maryland
6.
go back to reference Karcher RE, Nuttal KL (2001) Electrophoresis. In: Burtis CA, Ashwood ER (eds) Teitz’s fundamentals of clinical chemistry. WB Saunders Company, Philadelphia, pp 121–132 Karcher RE, Nuttal KL (2001) Electrophoresis. In: Burtis CA, Ashwood ER (eds) Teitz’s fundamentals of clinical chemistry. WB Saunders Company, Philadelphia, pp 121–132
7.
go back to reference Riches P (1990) Immunochemical investigation of lymphoid malignancies. In: Gooi HC, Chapel RC (eds) Clinical immunology: a practical approach. Oxford University Press, Oxford, pp 111–138 Riches P (1990) Immunochemical investigation of lymphoid malignancies. In: Gooi HC, Chapel RC (eds) Clinical immunology: a practical approach. Oxford University Press, Oxford, pp 111–138
8.
go back to reference Keren DF (1999) Procedures for the evaluation of monoclonal immunoglobulins. Arch Pathol Lab Med 123:126–132PubMed Keren DF (1999) Procedures for the evaluation of monoclonal immunoglobulins. Arch Pathol Lab Med 123:126–132PubMed
9.
go back to reference Hardisty RM, Weatherall DJ (1982) Blood and it disorders, 2nd edn. Blackwell Scientific Publications, St. Louis Hardisty RM, Weatherall DJ (1982) Blood and it disorders, 2nd edn. Blackwell Scientific Publications, St. Louis
10.
go back to reference Keren DF, Alexanian R, Goeken JA, Gore Vic PD, Kyle RA, Tomar RH (1999) Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch Path Lab Med 123:106–107PubMed Keren DF, Alexanian R, Goeken JA, Gore Vic PD, Kyle RA, Tomar RH (1999) Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch Path Lab Med 123:106–107PubMed
12.
go back to reference Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R (2001) Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47:673–680PubMed Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R (2001) Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47:673–680PubMed
14.
go back to reference Kyle RA, Greipp PR (1978) The laboratory investigation of monoclonal gammopathies. Mayo Clin Proc 53:719–739PubMed Kyle RA, Greipp PR (1978) The laboratory investigation of monoclonal gammopathies. Mayo Clin Proc 53:719–739PubMed
15.
go back to reference Jenkins MA (2009) Serum and urine electrophoresis for detection and identification of monoclonal proteins. Clin Biochem Rev 30:119–122PubMedCentralPubMed Jenkins MA (2009) Serum and urine electrophoresis for detection and identification of monoclonal proteins. Clin Biochem Rev 30:119–122PubMedCentralPubMed
16.
go back to reference Attaelmannan M, Levinson SS (2000) Understanding and identifying monoclonal gammopathies. Clin Chem 46(8 Pt 2):1230–1238PubMed Attaelmannan M, Levinson SS (2000) Understanding and identifying monoclonal gammopathies. Clin Chem 46(8 Pt 2):1230–1238PubMed
17.
go back to reference Kallemuchikkal U, Gorevic PD (1999) Evaluation of cryoglobulins. Arch Pathol Lab Med 123:119–125PubMed Kallemuchikkal U, Gorevic PD (1999) Evaluation of cryoglobulins. Arch Pathol Lab Med 123:119–125PubMed
18.
go back to reference Lock RJ, Virgo PF, Unsworth DJ (2008) Pitfalls in the performance and interpretation of clinical immunology tests. J Clin Pathol 61:1236–1242CrossRefPubMed Lock RJ, Virgo PF, Unsworth DJ (2008) Pitfalls in the performance and interpretation of clinical immunology tests. J Clin Pathol 61:1236–1242CrossRefPubMed
19.
go back to reference Kyle RA (1999) Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 123:114–118PubMed Kyle RA (1999) Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 123:114–118PubMed
20.
go back to reference Shustik C, Bergsagel DE, Pruzanski W (1976) Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood 48:41–51PubMed Shustik C, Bergsagel DE, Pruzanski W (1976) Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood 48:41–51PubMed
21.
go back to reference Anand M, Singh S, Kumar R, Sharma OD (2004) Value of immunofixation on serum in light-chain myeloma. Ann Clin Biochem 41:501–502CrossRefPubMed Anand M, Singh S, Kumar R, Sharma OD (2004) Value of immunofixation on serum in light-chain myeloma. Ann Clin Biochem 41:501–502CrossRefPubMed
22.
go back to reference Franklin EC (1975) Electrophoresis and immunoelectrophoresis in diagnosis of dysproteinemias. In: Vyas GN, Stites DP, Brecher G (eds) Laboratory diagnosis of immunologic disorders. Grune and Stratton, New York, pp 3–11 Franklin EC (1975) Electrophoresis and immunoelectrophoresis in diagnosis of dysproteinemias. In: Vyas GN, Stites DP, Brecher G (eds) Laboratory diagnosis of immunologic disorders. Grune and Stratton, New York, pp 3–11
23.
go back to reference Blade J, Lust JA, Kyle RA (1994) Immunoglobulin D multiple myeloma: presenting features, response to therapy and survival in a series of 53 cases. J Clin Oncol 12:2398–2404PubMed Blade J, Lust JA, Kyle RA (1994) Immunoglobulin D multiple myeloma: presenting features, response to therapy and survival in a series of 53 cases. J Clin Oncol 12:2398–2404PubMed
24.
go back to reference Pandey S, Kyle RA (2013) Unusual myelomas: a review of IgD and IgE variants. Oncology (Williston Park) 27:798–803 Pandey S, Kyle RA (2013) Unusual myelomas: a review of IgD and IgE variants. Oncology (Williston Park) 27:798–803
25.
go back to reference Kuliszkiewicz-Janus M, Zimny A, Sokolska V, Saşiadek M, Kuliczkowski K (2005) Immunoglobulin D myeloma—problems with diagnosing and staging (own experience and literature review). Leuk Lymphoma 46:1029–1037CrossRefPubMed Kuliszkiewicz-Janus M, Zimny A, Sokolska V, Saşiadek M, Kuliczkowski K (2005) Immunoglobulin D myeloma—problems with diagnosing and staging (own experience and literature review). Leuk Lymphoma 46:1029–1037CrossRefPubMed
26.
go back to reference Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W (1975) IgD multiple myeloma. Review of 133 cases. Arch Intern Med 135:87–93CrossRefPubMed Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W (1975) IgD multiple myeloma. Review of 133 cases. Arch Intern Med 135:87–93CrossRefPubMed
27.
go back to reference Kairemo KJ, Lindberg M, Prytz M (1999) IgE myeloma: a case presentation and a review of the literature. Scand J Clin Lab Invest 59:451–456CrossRefPubMed Kairemo KJ, Lindberg M, Prytz M (1999) IgE myeloma: a case presentation and a review of the literature. Scand J Clin Lab Invest 59:451–456CrossRefPubMed
28.
go back to reference Abraham RS, Charlesworth MC, Owen BA, Benson LM, Katzmann JA, Reeder CB et al (2002) Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma. Clin Chem 48:1805–1811PubMed Abraham RS, Charlesworth MC, Owen BA, Benson LM, Katzmann JA, Reeder CB et al (2002) Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma. Clin Chem 48:1805–1811PubMed
29.
go back to reference Vladutiu AO, Kohli RK (1977) Double spike in the electropherogram of myeloma serum, from Bence Jones protein. Clin Chem 23:140–142PubMed Vladutiu AO, Kohli RK (1977) Double spike in the electropherogram of myeloma serum, from Bence Jones protein. Clin Chem 23:140–142PubMed
30.
go back to reference Kyle RA (1975) Multiple myeloma: review of 869 cases. Mayo Clin Proc 50:29–40PubMed Kyle RA (1975) Multiple myeloma: review of 869 cases. Mayo Clin Proc 50:29–40PubMed
Metadata
Title
Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma
Authors
Aroonima Misra
Jyoti Mishra
Jagan Chandramohan
Atul Sharma
Vinod Raina
Rajive Kumar
Sushant Soni
Anita Chopra
Publication date
01-03-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0605-3

Other articles of this Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine